Cardio-oncology: what you need to know now for clinical practice and echocardiography
Open Access
- 1 March 2017
- journal article
- review article
- Published by Springer Nature in Echo Research & Practice
- Vol. 4 (1) , R33-R41
Abstract
Cardio-oncology is a rapidly growing field aimed at minimizing the effects of cardiovascular morbidity and mortality in cancer survivors. To meet this aim, patients are assessed at baseline to define their risk of cardiotoxicity and then followed closely during and after chemotherapy to assess for early signs or symptoms of cardiovascular disease. Cardiac imaging, and in particular, transthoracic echocardiography, plays an essential role in the baseline assessment and serial follow-up of cardio-oncology patients. The objectives of this paper are to review the mechanisms of cardiotoxicity of several common chemotherapeutic agents associated with an increased risk for left ventricular systolic dysfunction and to outline recommendations regarding the baseline assessment and serial follow-up of cardio-oncology patients with a focus on the role of echocardiography.Keywords
This publication has 33 references indexed in Scilit:
- Cardiovascular toxicity induced by chemotherapy, targeted agents and radiotherapy: ESMO Clinical Practice GuidelinesAnnals of Oncology, 2012
- Risk of Heart Failure in Breast Cancer Patients After Anthracycline and Trastuzumab Treatment: A Retrospective Cohort StudyJNCI: Journal of the National Cancer Institute, 2012
- Cardiotoxicity of anticancer treatments: what the cardiologist needs to knowNature Reviews Cardiology, 2010
- Cardiotoxicity of anthracycline agents for the treatment of cancer: Systematic review and meta-analysis of randomised controlled trialsBMC Cancer, 2010
- Cardiotoxicity of Anticancer Drugs: The Need for Cardio-Oncology and Cardio-Oncological PreventionJNCI: Journal of the National Cancer Institute, 2010
- Anthracycline-Induced CardiomyopathyJACC, 2010
- Cancer prevalence in the United Kingdom: estimates for 2008British Journal of Cancer, 2009
- Early reduction in left ventricular contractile reserve detected by dobutamine stress echo predicts high-dose chemotherapy-induced cardiac toxicityInternational Journal of Cardiology, 2006
- Prognostic Value of Troponin I in Cardiac Risk Stratification of Cancer Patients Undergoing High-Dose ChemotherapyCirculation, 2004
- Essential Roles of Her2/erbB2 in Cardiac Development and FunctionRecent Progress in Hormone Research, 2004